News

19 November 2018

Curie Cancer : the launch of biotechnology company Honing Biosciences

Institut Curie (Curie Cancer Carnot Institute) announces the launch of biotechnology company Honing Biosciences, a technology platform that develops solutions to optimize the efficiency and safety of cell therapies in cancer and chronic diseases.

Close

Curie Cancer : the launch of biotechnology company Honing Biosciences

Institut Curie (Curie Cancer Carnot Institute) announces the launch of biotechnology company Honing Biosciences, a technology platform that develops solutions to optimize the efficiency and safety of cell therapies in cancer and chronic diseases.

Cell-based therapy modify and use the cells to restore the function of a tissue or organ or to cure a disease. The goal is to provide long-term care for cancer patients through a single injection of therapeutic cells.

Honing Biosciences relies on proprietary technologies that enable precise control of cellular functions, providing a unique answer to current limitations.

More details

19 November 2018
9 November 2018

Curie Cancer Carnot Institute : a partnership with Philips to enhance oncology patients’ care

Philips and Institut Curie (Curie Cancer Carnot Institute) have decided to invest more than 250 000 euros each in a partnership linked to the clinical use of the nuclear medicine PET scan Vereos, the first and only entirely digital PET/CT currently available on the market. Such a system can offer improved spatial resolution, significant gain in sensitivity and a better precision compared to standard analog systems.

Close

Curie Cancer Carnot Institute : a partnership with Philips to enhance oncology patients’ care

Philips and Institut Curie (Curie Cancer Carnot Institute) have decided to invest more than 250 000 euros each in a partnership linked to the clinical use of the nuclear medicine PET scan Vereos, the first and only entirely digital PET/CT currently available on the market. Such a system can offer improved spatial resolution, significant gain in sensitivity and a better precision compared to standard analog systems.

Philips is honored to associate to Institut Curie (Curie Cancer Carnot Institute) in the framework of a long-lasting partnership whose purpose is to develop clinical research projects aiming at the improvement of cancer diagnostics and patient treatment. This project follows the acquisition by Institut Curie of a nuclear medicine digital system Philips Vereos, the first of its kind in the Paris region.

Read the press release

9 November 2018
9 November 2018

Cetim Carnot Institute : Fatigue Design 2019

Organized by Cetim Carnot Institute, the 8th Fatigue Design conference held in 2019 aims to present the most innovative approaches and scientific progress in design methodologies, tools, and equipment’s life extension, focusing on industrial applications.

For this edition, a new focus is made on the relation between additive manufacturing and fatigue.

Place : Senlis in France.

Date : From November 20, 2019 to November 21, 2019

More information about this event

 

9 November 2018

Earth System and Big Data : Launch of the European Infrastructure EPOS

Wednesday 7 November 2018 officially launches the European Plate Observing System (EPOS) for the pooling of data and services for the study of our planet. BRGM Carnot Institute is part of this initiative.

Read more
Close

Earth System and Big Data : Launch of the European Infrastructure EPOS

Wednesday 7 November 2018 officially launches the European Plate Observing System (EPOS) for the pooling and streamlining of data and services of all kinds for the study of our planet. This initiative, for which the BRGM Carnot Institute and CNRS are working together with the French Ministry for Higher Education, Research and Innovation, in part aims to better understand the mechanisms behind earthquakes and volcanic eruptions. Developed in line with the principles of open science, EPOS infrastructure will henceforth be a legal entity, in the form of a European Research Infrastructure Consortium (ERIC).

9 November 2018
2 July 2018

Leti Memory Workshop - Grenoble - France

Leti Carnot Institute organize Memory Workshop on eNVM, July 2nd 2018 - Grenoble - France.
This one-day workshop will explore short-term and long-term memory solutions. Industrials and experts will share their views, discuss start-up creation and introduce disruptive concepts that will soon penetrate the market. To expand our horizons, world-class academics will also provide their views on non-conventional applications.

More information

2 July 2018

Curie Cancer Carnot Institute names Intel lead partner to implement high performance computing and artificial intelligence in accelerating genome sequencing and interpretation for oncology

Curie Cancer Carnot Institute and Intel initiate a pioneering collaboration to develop, use and implement innovative Bioinformatics tools, pipelines and techniques to improve the use of molecular profiling across both research and clinical oncology settings.

Read the press release

19 April 2018

Leti Innovation Days - Grenoble - France

Leti Innovation Days 2018 on July 4-5th will include a series of keynotes and panel sessions from industry leaders and academics. Along the conference, a special exhibition will be open in the afternoons, and will gather microelectronics industrials and successful start-ups. 

This year, there will be 7 satellite workshops on various technical fields :

  • Design for 3D
  • Lithography
  • Quantum
  • Silicon photonics
  • Memory
  • 5 G
  • MEMS & sensors 

More information

 

 

 

19 April 2018

Curie Cancer Carnot Institute and Freenome announce a strategic collaboration in cell-free DNA analysis using machine learning technology

Curie Cancer Carnot Institute and Freenome announce a strategic collaboration to evaluate Freenome’s artificial intelligence (AI) genomics platform as a novel tool to predict patient response to immuno-oncology therapies by observing changes in circulating cell-free biomarkers.

Read more
Close

Curie Cancer Carnot Institute and Freenome announce a strategic collaboration in cell-free DNA analysis using machine learning technology

Curie Cancer Carnot Institute and Freenome announce a strategic collaboration to evaluate Freenome’s artificial intelligence (AI) genomics platform as a novel tool to predict patient response to immuno-oncology therapies by observing changes in circulating cell-free biomarkers.

In recent years so-called liquid biopsies have established the possibility of detecting circulating fragments of tumor DNA (ctDNA) and circulating tumor cells (CTCs) in the blood of patients with cancer. Institut Curie has been a pioneer in the field since the late 90’s with the first program on disseminated tumor cell (DTC) detection in the bone marrow of patients with early breast cancer. Since then, Institut Curie’s Circulating Tumor Biomarkers Laboratory has developed numerous innovative ctDNA techniques (ddPCR and NGS-based techniques).

Meanwhile, Freenome’s breakthrough use of machine learning looks beyond tumor DNA and processes the full range of cell-free (cf) biomarkers in the blood. By assembling an ever-expanding library of cell-free disease signatures, Freenome is developing a range of non-invasive blood tests for the early detection of cancer and early prediction of response to various oncology therapies. As a first step in this collaboration with Institut Curie, Freenome will analyze samples from the Analysis of Circulating Tumor Markers in the Blood (ALCINA) Trial, an umbrella trial allowing assessment of different circulating biomarkers and their correlation with clinical and pathological characteristics pertaining to response to PD-1 inhibitors alone and in combination with other therapies.

More information

19 April 2018
20 March 2018

The CALYM Carnot Institute and the Institut Roche, Partners to Accelerate Together Research against Lymphoma!

At the end of December 2017, a framework contract was signed between CALYM and the Institut Roche to define the terms of a joint call for projects for the development of preclinical and translational research partnerships in onco-hematology.

Read more
Close

The CALYM Carnot Institute and the Institut Roche, Partners to Accelerate Together Research against Lymphoma!

At the end of December 2017, a framework contract was signed between CALYM and the Institut Roche to define the terms of a joint call for projects for the development of preclinical and translational research partnerships in onco-hematology.

The CALYM Carnot institute aims at accelerating innovation and its transfer in the lymphoma field, particularly in the translational phase. To transform its discoveries of basic research into clinical applications for the patient, the institute benefits from the financial support of the French government (National Research Agency) andrelies on public-private partnerships it develops with industry and other research and technological organizations.

It is in this context that CALYM has come closer to the Institut Roche which missions are to lead and develop strategic projects of basic or translational research in partnership with the French research teams of excellence.

More information

20 March 2018

Pages